Duke/BMS partnership focuses on collaborative R&D

03/1/2012 | Genetic Engineering & Biotechnology News

Duke Translational Medicine Institute and Bristol-Myers Squibb announced a collaborative deal to develop a treatment for idiopathic pulmonary fibrosis. Longer-term goals include moving new drug candidates into proof-of-concept trials, boosting enrollment in clinical trials and developing disease education programs.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA